Artesunate
Back to searchMolecule Structure
Scientific Name
Artesunate
Description of the Drug
Artesunate is artesunate is an artemesinin derivative indicated for the initial treatment of severe malaria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09274
http://www.drugbank.ca/drugs/DB09274
Brand Name(s)
Arsumax
Company Owner(s)
Amivas Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL14552891 |
| Human Metabolome Database | HMDB0240267 |
| DrugBank | DB09274 |
| PubChem: Thomson Pharma | 16514266 |
| PubChem | 6917864 |
| Mcule | MCULE-7041587395 |
| Nikkaji | J258.545F |
| PDBe | D95 |
| BindingDB | 50248021 |
| DrugCentral | 247 |
| Guide to Pharmacology | 9956 |
| rxnorm | ARTESUNATE |
| PubChem: Drugs of the Future | 12013392 |
| ChEBI | 63918 |
| ZINC | ZINC000014096305 |
